Name
des98s
Label
SpO2 Range/Position: 98-100% Supine
Units
minutes
Type
numeric
Visit number vs SpO2 Range/Position: 98-100% Supine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 5.5 | ± 19.4 | 0.5 | 0.0 | 159.1 | 2 | 318 |
Follow-up | 275 | 16.3 | ± 47.3 | 0.8 | 0.0 | 379.8 | 26 | 301 |
Treatment Arm vs SpO2 Range/Position: 98-100% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.5 | ± 19.4 | 0.5 | 0.0 | 159.1 | 2 | 318 |
HLSE | 106 | 3.7 | ± 8.2 | 0.3 | 0.0 | 59.9 | - | 106 |
HLSE-O | 105 | 6.8 | ± 23.9 | 0.6 | 0.0 | 148.7 | 1 | 106 |
HLSE-P | 105 | 6.1 | ± 22.2 | 0.4 | 0.0 | 159.1 | 1 | 106 |
Treatment Arm vs SpO2 Range/Position: 98-100% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 16.3 | ± 47.3 | 0.8 | 0.0 | 379.8 | 26 | 301 |
HLSE | 94 | 3.1 | ± 9.3 | 0.3 | 0.0 | 75.1 | 6 | 100 |
HLSE-O | 95 | 38.9 | ± 73.5 | 6.7 | 0.0 | 379.8 | 6 | 101 |
HLSE-P | 86 | 5.7 | ± 16.8 | 0.4 | 0.0 | 97.7 | 14 | 100 |
Age category vs SpO2 Range/Position: 98-100% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.5 | ± 19.4 | 0.5 | 0.0 | 159.1 | 2 | 318 |
45-54 years | 52 | 9.0 | ± 29.5 | 1.1 | 0.0 | 159.1 | 1 | 53 |
55-64 years | 139 | 3.2 | ± 9.0 | 0.3 | 0.0 | 75.5 | - | 139 |
65 years or older | 125 | 6.7 | ± 22.2 | 0.5 | 0.0 | 148.7 | 1 | 126 |
Age category vs SpO2 Range/Position: 98-100% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 16.3 | ± 47.3 | 0.8 | 0.0 | 379.8 | 25 | 300 |
45-54 years | 42 | 17.1 | ± 40.1 | 0.5 | 0.0 | 224.7 | 7 | 49 |
55-64 years | 117 | 13.1 | ± 41.0 | 0.6 | 0.0 | 379.8 | 10 | 127 |
65 years or older | 116 | 19.2 | ± 55.2 | 1.2 | 0.0 | 360.4 | 8 | 124 |
Gender vs SpO2 Range/Position: 98-100% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 5.5 | ± 19.4 | 0.5 | 0.0 | 159.1 | 2 | 318 |
Female | 84 | 10.1 | ± 31.1 | 0.9 | 0.0 | 159.1 | - | 84 |
Male | 232 | 3.8 | ± 12.5 | 0.3 | 0.0 | 144.9 | 2 | 234 |
Gender vs SpO2 Range/Position: 98-100% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 16.3 | ± 47.3 | 0.8 | 0.0 | 379.8 | 26 | 301 |
Female | 73 | 32.9 | ± 76.7 | 1.6 | 0.0 | 379.8 | 6 | 79 |
Male | 202 | 10.3 | ± 28.5 | 0.7 | 0.0 | 189.4 | 20 | 222 |
Race vs SpO2 Range/Position: 98-100% Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 311 | 5.5 | ± 19.5 | 0.4 | 0.0 | 159.1 | 2 | 313 |
White | 251 | 2.8 | ± 7.3 | 0.3 | 0.0 | 75.5 | 1 | 252 |
Black | 41 | 18.2 | ± 43.3 | 0.8 | 0.0 | 159.1 | 1 | 42 |
Other | 19 | 14.3 | ± 33.2 | 2.7 | 0.0 | 144.9 | - | 19 |
Race vs SpO2 Range/Position: 98-100% Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 271 | 15.9 | ± 46.8 | 0.8 | 0.0 | 379.8 | 25 | 296 |
White | 219 | 9.8 | ± 33.5 | 0.6 | 0.0 | 379.8 | 18 | 237 |
Black | 34 | 49.5 | ± 86.2 | 7.9 | 0.0 | 360.4 | 6 | 40 |
Other | 18 | 26.8 | ± 55.7 | 4.0 | 0.0 | 224.7 | 1 | 19 |